Dem demands feds reject EpiPen settlement

Published



A Democratic senator on Monday demanded the Department of Justice reject a $465 million settlement with generic drug maker Mylan over allegations it scammed Medicaid out of reimbursements it owed through people using its EpiPen allergy drug.

Sen. Richard Blumenthal, D-Conn., sent a letter to DOJ to argue that Mylan did at least $700 million worth of harm to taxpayers by overpricing EpiPens, and that the settlement officials have reached is not enough of a penalty against the company.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.